-
1Academic Journal
Authors: Alexey S. Kolbin, Kseniya S. Radaeva, А. С. Колбин, К. С. Радаева
Contributors: Not specified., Отсутствует.
Source: Current Pediatrics; Том 22, № 4 (2023); 289-297 ; Вопросы современной педиатрии; Том 22, № 4 (2023); 289-297 ; 1682-5535 ; 1682-5527
Subject Terms: разработка лекарств, dosing, medications, population pharmacokinetics, physiologically based pharmacokinetic model, clinical studies, drug design, дозирование, лекарственные средства, популяционная фармакокинетика, физиологически обоснованная фармакокинетическая модель, клинические исследования
File Description: application/pdf
Relation: https://vsp.spr-journal.ru/jour/article/view/3262/1307; ICH Harmonised Guideline Pediatric Extrapolation E11A ICH Consensus Guideline. 2022. Available online: https://www.ema.europa.eu/en/documents/scientific-guideline/draft-ich-guideline-e11a-pediatric-extrapolation-step-2b_en.pdf. Accessed on July 22, 2023.; Food and Drug Administration Modernization Act of 1997: Text S.830. 105th Congress (1997-1998). In: Congress.gov. Available online: https://www.congress.gov/bill/105th-congress/senate-bill/830/text. Accessed on July 22, 2023.; Колбин А.С. Клиническая фармакология для педиатров: учебное пособие. — М.: ГЭОТАР-Медиа; 2020. — 288 с.; The European Agency for the Evaluation of Medicinal Products, Human Evaluations Unit. Report on the experts round table on the difficulties related to the use of new medicinal products in children held on 18 December 1997. EMEA/27164/98 Rev. 1. London, 30 July 1998. Available online: https://www.ema.europa.eu/en/documents/report/report-experts-round-table-difficulties-related-use-new-medicinal-products-children-held-18-december_en.pdf. Accessed on July 22, 2023.; Best Pharmaceuticals for Children Act. Summary: Text S.3452. 107th Congress (2001-2002). In: Congress.gov. Available online: https://www.congress.gov/bill/107th-congress/senate-bill/1789/text. Accessed on July 22, 2023.; Pediatric Research Equity Act of 2003: Text S.650. 108th Congress (2003-2004). In: Congress.gov. Available online: https://www.congress.gov/bill/108th-congress/senate-bill/650/text. Accessed on July 22, 2023.; Намазова-Баранова Л.С., Садеки Н., Баранов А.А. Открытые вопросы клинических исследований с участием детей в качестве субъектов исследования: обзор литературы. Педиатрическая фармакология. 2022;19(1):61-71. https://doi.org/10.15690/10.15690/pf.v19i1.2375; Завидова С., Намазова-Баранова Л., Тополянская С. Клинические исследования лекарственных препаратов в педиатрии: проблемы и достижения. Педиатрическая фармакология. 2010; 7(1):6-14.; Burckart GJ, van den Anker JN. Neonatal and Pediatric Dose Selection: Quo Vadis? J Clin Pharmacol. 2021;61(Suppl 1):S7-S8. doi: https://doi.org/10.1002/jcph.1888; Powell JR, Cook J, Wang Y, et al. Drug Dosing Recommendations for All Patients: A Roadmap for Change. Clin Pharmacol Ther. 2021;109(1):65-72. doi: https://doi.org/10.1002/cpt.1923; Elias GP, Antoniali C, Mariano RC. Comparative study of rules employed for calculation of pediatric drug dosage. J Appl Oral Sci. 2005;13(2):114-119. doi: https://doi.org/10.1590/s1678-77572005000200004; van Rongen A, Krekels EH, Calvier EA, et al. An Update on the Use of Allometric and Other Scaling Methods to Scale Drug Clearance in Children: Towards Decision Tables. Expert Opin Drug Metab Toxicol. 2022;18(2):99-113. doi: https://doi.org/10.1080/17425255.2021.2027907; Momper JD, Mulugeta Y, Green DJ, et al. Adolescent dosing and labeling since the Food and Drug Administration Amendments Act of 2007. JAMA Pediatr. 2013;167(10):926-932. doi: https://doi.org/10.1001/jamapediatrics.2013.465; Tegenge MA, Mahmood I. Age- and Bodyweight-dependent Allometric Exponent Model for Scaling Clearance and Maintenance Dose of Theophylline From Neonates to Adults. Ther Drug Monit. 2018;40(5):635-641. doi: https://doi.org/10.1097/FTD.0000000000000543; Holford N. Dosing in children. Clin Pharmacol Ther. 2010; 87(3):367-370. doi: https://doi.org/10.1038/clpt.2009.262; Johnson TN, Ke AB. Physiologically Based Pharmacokinetic Modeling and Allometric Scaling in Pediatric Drug Development: Where Do We Draw the Line? J Clin Pharmacol. 2021;61 (Suppl 1):S83-S93. doi: https://doi.org/10.1002/jcph.1834; Calvier EA, Krekels EH, Valitalo PA, et al. Allometric Scaling of Clearance in Paediatric Patients: When Does the Magic of 0.75 Fade? Clin Pharmacokinet. 2017;56(3):273-285. doi: https://doi.org/10.1007/s40262-016-0436-x; Malik PRV, Temrikar ZH, Chelle P, et al. Pediatric Dose Selection for Therapeutic Proteins. J Clin Pharmacol. 2021;61(Suppl 1): S193-S206. doi: https://doi.org/10.1002/jcph.1829; Mahmood I, Tegenge MA. Spreadsheet-Based Minimal Physiological Models for the Prediction of Clearance of Therapeutic Proteins in Pediatric Patients. J Clin Pharmacol. 2021;61 (Suppl 1):S108-S116. doi: https://doi.org/10.1002/jcph.1846; Perry C, Davis G, Conner TM, Zhang T. Utilization of Physiologically Based Pharmacokinetic Modeling in Clinical Pharmacology and Therapeutics: an Overview. Curr Pharmacol Rep. 2020;6(3):71-84. doi: https://doi.org/10.1007/s40495-020-00212-x; Salerno SN, Edginton A, Gerhart JG, et al. Physiologically-based pharmacokinetic modeling characterizes the CYP3A-mediated drug-drug interaction between fluconazole and sildenafil in infants. Clin Pharmacol Ther. 2021;109(1):253-262. doi: https://doi.org/10.1002/cpt.1990; Grimstein M, Yang Y, Zhang X, et al. Physiologically Based Pharmacokinetic Modeling in Regulatory Science: An Update From the U.S. Food and Drug Administration's Office of Clinical Pharmacology. J Pharm Sci. 2019;108(1):21-25. doi: https://doi.org/10.1016/j.xphs.2018.10.033; Gonzalez D, Sinha J. Pediatric Drug-Drug Interaction Evaluation: Drug, Patient Population, and Methodological Considerations. J Clin Pharmacol. 2021;61(Suppl 1):S175-S187. doi: https://doi.org/10.1002/jcph.1881; Smits A, Kulo A, van den Anker J, Allegaert K. The amikacin research program: a stepwise approach to validate dosing regimens in neonates. Exp Opin Drug Metabol Toxicol. 2017;13(2):157-166. doi: https://doi.org/10.1080/17425255.2017.1234606; Kalaria SN, Farchione TR, Uppoor R, et al. Extrapolation of Efficacy and Dose Selection in Pediatrics: A Case Example of Atypical Antipsychotics in Adolescents With Schizophrenia and Bipolar I Disorder. J Clin Pharmacol. 2021;61(Suppl 1):S117-S124. doi: https://doi.org/10.1002/jcph.1836; Тихов М.С., Шкилева К.Н. Модифицированный метод оценивания Рида и Менча в зависимости доза-эффект // Вестник Тверского государственного университета. Серия: Прикладная математика. — 2019. — № 4. — С. 5-26. — doi: https://doi.org/10.26456/vtpmk543; Khurana M. Renal Impairment in Pediatric Patients: Current Approaches to Drug Dosing. J Clin Pharmacol. 2021;61(Suppl 1): S161-S164. doi: https://doi.org/10.1002/jcph.1908; Zhang Q, Travis J, Rothwell R, et al. Applying the Noninferiority Paradigm to Assess Exposure-Response Similarity and Dose Between Pediatric and Adult Patients. J Clin Pharmacol. 2021;61(S1): S165-S174. doi: https://doi.org/10.1002/jcph.1885; Ramsey LB, Brown JT, Vear SI, et al. Gene-Based Dose Optimization in Children. Annu Rev Pharmacol Toxicol. 2020;60:311-331. doi: https://doi.org/10.1146/annurev-pharmtox-010919-023459; Hoshitsuki K, Fernandez CA, Yang JJ. Pharmacogenomics for Drug Dosing in Children: Current Use, Knowledge, and Gaps. J Clin Pharmacol. 2021;61(S1):S188-S192. doi: https://doi.org/10.1002/jcph.1891; Relling MV, Pui CH, Cheng C, Evans WE. Thiopurine methyltrans-ferase in acute lymphoblastic leukemia. Blood. 2006;107(2): 843-844. doi: https://doi.org/10.1182/blood-2005-08-3379; Hahn D, Fukuda T, Euteneuer JC, et al. Influence of MRP3 Genetics and Hepatic Expression Ontogeny for Morphine Disposition in Neonatal and Pediatric Patients. J Clin Pharmacol. 2020;60(8): 992-998. doi: https://doi.org/10.1002/jcph.1592; Ward RM, Tammara B, Sullivan SE, et al. Single-dose, multiple-dose, and population pharmacokinetics of pantoprazole in neonates and preterm infants with a clinical diagnosis of gastroesophageal reflux disease (GERD). Eur J Clin Pharmacol. 2010;66(6):555-561. doi: https://doi.org/10.1007/s00228-010-0811-8; Хохлов А.Л., Сычев Д.А. Концепция пациентоориентированности в медицине и фармации // Пациентоориентированная медицина и фармация. — 2023. — Т. 1. — № 1. — С. 1-4. — doi: https://doi.org/10.37489/2949-1924-0001; Решение Совета ЕЭК от 17 марта 2022 г. № 36 «О внесении изменений в Правила регистрации и экспертизы лекарственных средств для медицинского применения».; Barrett JS, Barrett RF, Vinks AA. Status Toward the Implementation of Precision Dosing in Children. J Clin Pharmacol. 2021; 61(Suppl1):S36-S51. doi: https://doi.org/10.1002/jcph.1830; Jarugula P, Scott S, Ivaturi V, et al. Understanding the Role of Pharmacometrics-Based Clinical Decision Support Systems in Pediatric Patient Management: A Case Study Using Lyv Software. J Clin Pharmacol. 2021;61(Suppl 1):S125-S132. doi: https://doi.org/10.1002/jcph.1892; Колбин А.С., Белоусов Д.Ю., Зырянов С.К. и др. Исследования реальной клинической практики / под ред. А.С. Колбина. — М.: Издательство ОКИ; Буки Веди; 2020. — 208 с.; Гусев А.В., Зингерман Б.В., Тюфилин Д.С., Зинченко В.В. Электронные медицинские карты как источник данных реальной клинической практики // Реальная клиническая практика: данные и доказательства. — 2022. — Т. 2. — № 2. — С. 8-20. — doi: https://doi.org/10.37489/2782-3784-myrwd-13; van den Anker J, Allegaert K. Considerations for Drug Dosing in Premature Infants. J Clin Pharmacol. 2021;61(Suppl 1): S141-S151. doi: https://doi.org/10.1002/jcph.1884.; Green FG, Park K, Burckart GJ. Methods Used for Pediatric Dose Selection in Drug Development Programs Submitted to the US FDA 2012-2020. J Clin Pharmacol. 2021;61(Suppl 1):S28-S35. doi: https://doi.org/10.1002/jcph.1853; Vinks AA, Barrett JS. Model-Informed Pediatric Drug Development: Application of Pharmacometrics to Define the Right Dose for Children. J Clin Pharmacol. 2021;61(Suppl 1):S52-S59. doi: https://doi.org/10.1002/jcph.1841